[1]
S. I. Stan, “Future therapeutic perspectives in nonalcoholic fatty liver disease: a focus on nuclear receptors, a promising therapeutic target”, Medicine and Pharmacy Reports, vol. 97, no. 2, pp. 111-119, Nov. 2023.